Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism
{{output}}
Purpose: Palopegteriparatide is a prodrug of parathyroid hormone (PTH) (1-34), administered once daily. It is designed to provide active PTH within the physiologic range for 24 hours/day. The effects of palopegteriparatide on ser... ...
